Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma

• Published in: Radiotherapy and oncology Vol. 37; no. 1; pp. 1 - 9
• Main Authors: Levine, E.L., Renehan, A., Gossiel, R., Davidson, S.E., Roberts, S.A., Chadwick, C., Wilks, D.P., Potten, C.S., Hendry, J.H., Hunter, R.D., West, C.M.L.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 01-10-1995
• Subjects: Adult; Aged; Apoptosis; Carcinoma, Squamous Cell - pathology; Carcinoma, Squamous Cell - radiotherapy; Cell Division; Cervical carcinoma; Disease-Free Survival; Female; Follow-Up Studies; Forecasting; Humans; Ki-67 Antigen; Middle Aged; Mitosis; Multivariate Analysis; Neoplasm Proteins - analysis; Neoplasm Recurrence, Local - prevention & control; Nuclear Proteins - analysis; Prognosis; Proliferation; Radiation Tolerance; Radiosensitivity; Radiotherapy; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms - pathology; Uterine Cervical Neoplasms - radiotherapy; Radiosensitivity; Proliferation; Cervical carcinoma; Radiotherapy; Apoptosis
• ISSN: 0167-8140; 1879-0887
• DOI: 10.1016/0167-8140(95)01622-N

Apoptosis is an important mechanism of cell death in tumours and it is seen both prior to and following radiotherapy. In this study patients with proven carcinoma of the cervix had measurement made of the percentage of apoptotic cells (apoptotic index or AI) in pre-therapy biopsies. Measurements of intrinsic radiosensitivity (SF2), already shown to be a predictor of outcome, had previously been made on the same pre-therapy biopsies. Mitotic index (MI) and Ki-67 antigen staining were also recorded as markers for proliferation. Patients were divided into those with an AI above or below the median and in general increasing apoptosis was associated with poor prognosis. The 5-year survival rate for tumours with an AI below the median was 79% and was significantly greater than the rate of 47% for those with an AI above the median (
p = 0.003). There was also a significantly increased 5-year local recurrence-free rate for patients with an AI below the median compared with those with an AI above the median (79 versus 61%,
p = 0.012). In addition, AI and SF2 acted as independent prognostic indicators. Patients with both an SF2 and AI value above the median did badly (25% 5-year survival, 46% local control) compared with those with an SF2 and AI below the median (80% 5-year survival, 100% local control). Apoptosis showed correlation with MI (
n = 66,
r = 0.34,
p = 0.002) and cell staining for the Ki-67 antigen (
n = 57,
r = 0.25,
p = 0.03), but neither MI nor Ki-67 were related to patient outcome. This suggests that while apoptosis may be a reflection of tumour proliferation this cannot in itself explain the ability of apoptosis to predict clinical outcome for this series of patients. The study raises the possibility of AI and SF2 being used together as predictors of tumour response to radiotherapy.